Abstract-Lack of effective tools to diagnose lung cancer at an early stage has caused high mortality in cancer patients especially in lung cancer patients. Electronic nose (E-Nose) technology is believed to offer non-invasive, rapid and reliable analytic approach by measuring the odour released from cancer to assist medical diagnosis. In this work, using a commercial E-nose (Cyranose-320), we aimed to detect the volatile organic compounds (VOCs) emitted by different types of cancerous cells. The lung cancer cell (A549) and breast cancer cell (MCF-7) were used for this study. Both cells were cultured using Dulbecco's Modified Eagle's Medium (DMEM) with 10% of Fetal Bovine Serum (FBS) and incubated for three days. The static headspace of cell cultures and blank medium were directly sniffed by Cyranose-320. The preliminary results from this study showed that, the E-nose is able to detect and distinguish the presence of VOCs in cancerous cells with accuracy of 100% using LDA. To this end, the VOCs emitted from cancerous cells can potentially used as biomarker.
I. INTRODUCTION
Lung cancer is one of the most common causes of cancer related mortality among human compared to other diseases in this world. Lung cancer patients are believed to have great survival expectation which is 5 years after being diagnosed if the tumor is diagnosed at early stages or at least in the 1 st stage [1] . Yet, only 15% of the lung cancers are detected at early stages and this has led to have very low percentages of 5-years survival rate of patients which is 16% [2] . These phenomena might be a result of the lack of effectiveness of screening techniques used to detect early lung cancer. Studies conducted in the 1970s and 1980s using chest radiography and sputum cytology as screening tools could not provide not provide evidence on reduction on lung cancer based mortality. Another study by National Lung Cancer Screening Trials (NLST) teams, using Low Dose Computed Tomography (LDCT) shows 20% of improvement on Therefore, for the past few decades, researchers keep on investigating the use of an advanced method to detect lung cancer by analyzing volatile organic compounds (VOCs) present in the tissue and exhaled breath of lung cancer patients. VOCs which are generated inside the cells are released by the blood cells and spread to alveolus where they are expired with breath [6] . As such, VOCs can be potentially used as biomarkers for lung cancer. This initiates the use of various separation techniques such as gas spectrometry with mass spectrometry (GCMS), to identify the compounds in both lung cancer tissues and exhaled breath of lung cancer patients [7] . However, these separation based techniques are still unable to fully discriminate smells according to tumors or pathogens [8] . It is useful to have a rapid detection, portable, sensitive and non-invasive technology such as electronic nose to detect and distinguish between the odour marks of cancerous growth [9] .
A. Electronic Nose (E-Nose)
An E-Nose is a highly sensitive technology that is able to sense and recognize the mixtures of compounds present or released from organic sources like multi-cellular organisms [10] . This technology has rapidly developed and commonly used in medical field [11] such as for diagnosis of ventilator associated pneumonia infection [12] - [14] , cerebrospinal fluid [15] [16] and identification of bacterial pathogens [15] [17] .
The Cyrano Science's Cyranose 320 (Smith Detections, Pasedena, CA) electronic nose is one of the commercially available portable systems which contain an array of 32 individual conducting polymer sensors and a signal processing system. When the sensors interact with the vapours or volatile organic compounds, the conductance of the polymers will change and cause an increase in the resistance value which can be used for characterization of a specific odour. All the setting for determination methods, training classes and the raw data can be stored for additional analysis on Windows based PC using PC nose software [18] .
In this preliminary study, we investigated the use of Cyranose-320 system to differentiate the VOCs of lung cancer cell, A549 and compared to the breast cancer, MCf-7. The blank culture was used as reference or baseline samples. 
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B. Feature reduction
The common feature reduction techniques used for ENose are unsupervised approach which is Principal Component Analysis (PCA) and supervised approach, Linear Discriminant Analysis (LDA) technique. A PCA technique projects the data in the direction of maximum separability. However, the PCA technique did not use the information of a signal based on classes as it projects all the data regardless of their class label. Therefore, this direction does not normally give the maximum separation between the classes meanwhile, LDA technique is reported to provide efficient and highest variability between classes in the data when there is class label information available [19] [20] . The LDA calculate projection by maximizing the variability between classes and minimizing the variability within classes. This ensures the dimensionality reduction and classification achieve the maximum class discrimination [21] [22].
II. METHODS
A. Cell Culturing Process
A549 adenocarcinoma cell line (ATCC® No: CCL-185) and breast adenocarcinoma cell line, MCF-7 (ATCC® No: HTB-22TM) were provided by Cell and Tissue Engineering Lab, International Islamic University Malaysia. These cells were cultivated using Dulbecco's Modified Eagle's Medium(DMEM) with (10%) bovine fetal serum (FBS) at 37°C in a humidified atmosphere of 5.0% CO2.
B. Design of Experiment
Adherent cells are grown monolayer on the specially treated surface of tissue culture flasks. The confluent cells at passage 3 were harvested by washing them with phosphate buffered solution (PBS) and detached using accutase (3ml). The detached cells then counted by using trypan blue dye exclusion method and seeded into T-25cm 2 flasks containing 5.0ml culture medium, with the concentration of 1x10 5 cells/ml. The prepared samples were incubated in a humidified atmosphere of 5% of CO2 at 37°C. To obtain the baseline values, blank culture mediums without cells were also prepared. Since the A549 cells were 70-80% confluent at 72 hours incubation, the MCF7 cells and blank medium samples were also incubated for 72 hours to standardize the experiment. Since the A549 cells were 70-80% confluent at 72 hours incubation, the MCF7 cells and blank medium samples were also incubated for 72 hours to standardize the experiment. All samples were evaluated in triplicates and average data were analysed. Table 1 shows the summary of cell lines used. The sampling of VOCs on the headspace of the samples was taken every 24 hours after incubation to investigate the volatile released at different cell confluence. The Cyranose-320 was used to sniff headspace of the samples and transfer the smell to the sensors without adjusting their composition and properties. To sniff the odour released by samples, the inlet/snout of Cryanose-320 was inserted into closed T-25cm 2 flasks for 15 minutes. The sniffing of the E -nose was repeated for 5 times and each sniffing was conducted for 3 minutes.
C. Statistical Analysis Technique
Commercial software, Matlab (Mathworks, Natick, MA) was used to extract relevant data from the 32 individual sensors raw data [23] . The extracted data then, were analysed using Linear Discriminant Analysis (LDA) technique [24] [20].
III. RESULT AND DISCUSSION
To examine the capability of Cryanose-320 in distinguishing the volatile organic compounds emitted from different cancer cells, the data collected were first analyzed using Principal Component Analysis (PCA). Then the result was further compared using prediction classifier, Linear Discriminant Analysis (LDA) method. Figure 2 shows the PCA plotting of volatiles detected from different cancer cells, A549 (lung cancer cell) and MCF-7 (breast cancer cell) and blank for (a) day 1, (b) day 2, (c) day 3 and (d) combination of all days. The PCA result of day 1 shows the total variation of 92.15%. The first principal component (PC) accounted for 81.28% and the second PC accounted for 10.87%. The PCA analysis for day 2 shows that the total variation among those cells and blank medium is 90.70% with the first PC explained 59.43% and the second PC explained 31.27%. For day 3, the first PC and second PC reported 50.18% and 36.48% respectively, with total variation of 86.66%. The PCA analysis in combination of all three days shows that the total variation is 69.1% with first PC reports 52.38% and second PC is 16.72%.
According to the result from PCA analysis, it is clearly shown that good variation has been plotted between these three different samples (A549, MCF-7 and blank) and this indicates that E-Nose is able to distinguish different types of cancer cells. However, for better classification and separation of clustering, the Linear Discriminant Analysis (LDA) was sought as indicated in Figure 3 . It is found that LDA plot gives 100% classification and no overlapping between different cancer cells (lung cancer and breast cancer) or blank at different day. For day 1, the total discriminant function is 100% with LDA function 1 counted as 90.00% and function 2 reported as 10.00%. The total discriminant for day 2 also accounted as 100% with function 1 for 93.6% and function 2 for 6.4%. The total discriminant for day 3 is 100%. The LDA function 1 accounted for 93.9% and function 2 accounted for 6.1%. Meanwhile, the total variance function for combination for 3 different days reported as 100%, which consists of 97.1% of LDA function 1 while 2.9% for function 2. This verified that E-Nose is able to distinguish and classify volatiles of cancer cells effectively.
The results demonstrated that the data set obtained from E-Nose can be used to distinguish different types of cancer based on their volatiles with the help of statistical data analysis method. The LDA analysis shows better splitting of distance and clustering. Meanwhile, PCA is useful to project the correlation of each data sample. In further work, we will continue the experiment by distinguishing more cancer cell lines using E-nose. The recommended methods will be tested with lung cancer and normal lung cell volatiles to examine the potential of e-nose to classify lung cancer accurately according to the types and stages of lung cancer. The next step will then be on testing of the efficiency and reliability of e-nose to detect VOCs of the exhaled air breath from the lung cancer patients in a clinical setting as an alternative method for lung cancer screening. 
